Concepedia

Vasyl Vasko

VV

28

Publications

2K

Citations

22

H-Index

2006

Active since

Affiliations

Uniformed Services University of the Health Sciences(Current)

MedStar Washington Hospital Center

The Ohio State University

National Institute of Diabetes and Digestive and Kidney Diseases

MedStar Georgetown University Hospital

Vasyl Vasko is an author at Uniformed Services University of the Health Sciences specializing in medicine, tumor biology, and pathology.

ORCID

Top concepts

Publications per year

2006–2020

28

Publications

28

Phase II Trial of Sorafenib in Metastatic Thyroid Cancer

Richard T. Kloos, Matthew D. Ringel, Michael V. Knopp et al. · Journal of Clinical Oncology · 2009 · 543 citations · Full text

Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer

Elaine T. Lam, Matthew D. Ringel, Richard T. Kloos et al. · Journal of Clinical Oncology · 2010 · 373 citations

Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer <i>In Vitro</i> and <i>In Vivo</i>

Shilpa Thakur, Brianna Daley, Kelli Gaskins et al. · Clinical Cancer Research · 2018 · 158 citations · Full text

Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10

Kevin Oakley, Yufen Han, Bandana Ajay Vishwakarma et al. · Blood · 2012 · 112 citations · Full text

Treatment With Metformin Is Associated With Higher Remission Rate in Diabetic Patients With Thyroid Cancer

Joanna Kłubo-Gwieździńska, John Costello, Aneeta Patel et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 103 citations · Full text

Rows per page

1–5 of 28